| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 38.7693 | 4 |
| GSM780708 | Untreated after 4 days (C2_1) | 46.7194 | 35 |
| GSM780709 | Untreated after 4 days (C3_1) | 46.1302 | 33 |
| GSM780719 | Untreated after 4 days (C1_2) | 40.4015 | 8 |
| GSM780720 | Untreated after 4 days (C2_2) | 47.1282 | 37 |
| GSM780721 | Untreated after 4 days (C3_2) | 35.2328 | 1 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 39.4041 | 5 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 46.66 | 35 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 39.2581 | 5 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 39.1623 | 4 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 40.1759 | 7 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 43.0065 | 17 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 40.5207 | 8 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 39.1784 | 4 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 49.0547 | 45 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 37.8794 | 2 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 43.5303 | 20 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 43.4851 | 20 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 40.7892 | 9 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 45.2213 | 28 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 35.6484 | 1 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 44.4067 | 24 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 45.0595 | 27 |